143 related articles for article (PubMed ID: 18702691)
1. Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis.
Stam NC; Nithianantharajah J; Howard ML; Atkin JD; Cheema SS; Hannan AJ
Eur J Neurosci; 2008 Aug; 28(4):717-23. PubMed ID: 18702691
[TBL] [Abstract][Full Text] [Related]
2. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
3. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
4. Behavioural effects of cage systems on the G93A Superoxide Dismutase 1 transgenic mouse model for amyotrophic lateral sclerosis.
Guerra S; Chung R; Yerbury J; Karl T
Genes Brain Behav; 2021 Jun; 20(5):e12735. PubMed ID: 33871173
[TBL] [Abstract][Full Text] [Related]
5. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
[TBL] [Abstract][Full Text] [Related]
7. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
8. Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS).
Knippenberg S; Thau N; Dengler R; Petri S
Behav Brain Res; 2010 Nov; 213(1):82-7. PubMed ID: 20450936
[TBL] [Abstract][Full Text] [Related]
9. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
[TBL] [Abstract][Full Text] [Related]
10. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
Srivastava AK; Gross SK; Almad AA; Bulte CA; Maragakis NJ; Bulte JWM
Exp Neurol; 2017 Mar; 289():96-102. PubMed ID: 28038988
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
12. Effects of environmental enrichment on the amyotrophic lateral sclerosis mouse model.
Sorrells AD; Corcoran-Gomez K; Eckert KA; Fahey AG; Hoots BL; Charleston LB; Charleston JS; Roberts CR; Markowitz H
Lab Anim; 2009 Apr; 43(2):182-90. PubMed ID: 19246505
[TBL] [Abstract][Full Text] [Related]
13. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis.
Glas M; Popp B; Angele B; Koedel U; Chahli C; Schmalix WA; Anneser JM; Pfister HW; Lorenzl S
Exp Neurol; 2007 Oct; 207(2):350-6. PubMed ID: 17716658
[TBL] [Abstract][Full Text] [Related]
14. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome.
Alves CJ; de Santana LP; dos Santos AJ; de Oliveira GP; Duobles T; Scorisa JM; Martins RS; Maximino JR; Chadi G
Brain Res; 2011 Jun; 1394():90-104. PubMed ID: 21354109
[TBL] [Abstract][Full Text] [Related]
15. Ascending neuropathology in the CNS of a mutant SOD1 mouse model of amyotrophic lateral sclerosis.
Leichsenring A; Linnartz B; Zhu XR; Lübbert H; Stichel CC
Brain Res; 2006 Jun; 1096(1):180-95. PubMed ID: 16737688
[TBL] [Abstract][Full Text] [Related]
16. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Sharp PS; Dick JR; Greensmith L
Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
[TBL] [Abstract][Full Text] [Related]
17. Increased anxiety-like behavior and selective learning impairments are concomitant to loss of hippocampal interneurons in the presymptomatic SOD1(G93A) ALS mouse model.
Quarta E; Bravi R; Scambi I; Mariotti R; Minciacchi D
J Comp Neurol; 2015 Aug; 523(11):1622-38. PubMed ID: 25684566
[TBL] [Abstract][Full Text] [Related]
18. Optimal methods to characterize the G93A mouse model of ALS.
Miana-Mena FJ; Muñoz MJ; Yagüe G; Mendez M; Moreno M; Ciriza J; Zaragoza P; Osta R
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):55-62. PubMed ID: 16036427
[TBL] [Abstract][Full Text] [Related]
19. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression.
Sharp PS; Akbar MT; Bouri S; Senda A; Joshi K; Chen HJ; Latchman DS; Wells DJ; de Belleroche J
Neurobiol Dis; 2008 Apr; 30(1):42-55. PubMed ID: 18255302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
